Eligo Bioscience

Eligobiotics”, a new generation of antimicrobials that can be programmed to target bacteria based on their genome. Eligobiotics therefore provide a new approach to explore, understand and control bacterial ecosystems both in human and animals. They can notably be used to selectively eradicate harmful pathogens from the microbiome while sparing beneficial ones.
Company Growth (employees)
Paris, FR
Size (employees)
8 (est)-11%
Eligo Bioscience was founded in 2014 and is headquartered in Paris, FR

Eligo Bioscience Office Locations

Eligo Bioscience has office in Paris
Paris, FR

Eligo Bioscience Metrics

Eligo Bioscience Summary

Founding Date


Total Funding

$2.2 m

Latest funding size

$2.2 m

Time since last funding

over 1 year


We estimate that Eligo Bioscience's latest funding round in July 2015 was $2.2 m. In total, Eligo Bioscience has raised $2.2 m

Eligo Bioscience Online Presence

Eligo Bioscience News

Eligo Bioscience Company Life

You may also be interested in